Press "Enter" to skip to content

Letter: Profits before care?

Editor, Gazette-Journal:

“The altruistic beginnings of insulin have morphed into a big money industry where the players boost profits before care,” Craig Idlebrook wrote on on June 21, 2017.

The researchers at University of Toronto who discovered insulin in 1921, “patented their work on insulin therapy… when they famously sold their rights to insulin to the University of Toronto for $3 in 1923.”

“Insulin … has not been significantly improved in the past 100 years … Today, three companies control the nearly 100 percent of the world’s insulin: Eli Lilly, Sanofi and Novo Nordisk,” reports The Hill, 3/31/22.

“The price of insulin has soared in the U.S. in the past 20 years, while it has stayed the same in other developed countries. A vial of insulin that cost $21 in 1999 in the U.S. cost $332 in 2019. Currently, insulin costs ten times more in the United States than in any other developed country,” reports Heather Cox Richardson, Letters From Americans, April...

To view the rest of this article, you must log in. If you do not have an account with us, please subscribe here.